Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Utilizing the patient activation measure (pam) as part of comprehensive medication review services for complex, high-risk patients.
- At: Seville (Spain) (2022)
- Type: Poster
- Poster code: PPR-045
- By: MCKEIRNAN, Kimberly (Washington State University College Of Pharmacy and Pharmaceutical Sciences, United States)
- Co-author(s): Dr Kimberly McKeirnan, Associate Professor (Washington State University College Of Pharmacy and Pharmaceutical Sciences, Spokane, United States)
Dr. Megan Undeberg, Pharmacotherapy
The Patient Activation Measure (PAM) is a validated and reliable tool designed to assess a patient’s level of engagement in managing their own health. PAM has been used in multiple sectors of the healthcare industry but there is limited data from pharmacists using this tool to identify and address medication-related problems (MRPs)... The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019